logo
INO_logo
INOVIO's management will host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss financial results and provide a general business update for the third quarter

INOVIO Reports Financial Results and Highlights for the Third Quarter 2022

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, today reported financial results for the quarter and nine months ended September 30, 2022

By AP News
Published - Nov 08, 2022, 05:12 PM ET
Last Updated - Mar 21, 2024, 02:20 PM EDT
  • Announced positive interim data for INO-3107 as a potential first-in-class treatment for Recurrent Respiratory Papillomatosis
  • Advanced strategy to focus on developing candidates that have the greatest opportunity for near-term success
  • Updates prior financial guidance and extends cash runway into first quarter of 2025
    • Article Source
    Quick Links
    Categories
    Our Offices
    • 10kInfo, Inc.
      13555 SE 36th St
      Bellevue, WA 98006
    • 10kInfo Data Solutions, Pvt Ltd.
      Claywork Create
      11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
      Bengaluru, Karnataka 560076
    4.2 12182024